Skip to main content
. 2024 Mar 29;23:108. doi: 10.1186/s12933-024-02199-x

Table 4.

Comparison of clinical characteristics and CT parameters in GLDIS T2DM patients and non-GLDIS T2DM patients after propensity matching

Variables GLDIS T2DM patients Non-GLDIS T2DM patients P
n 92 92
Age (years) 62.08 ± 11.17 62.58 ± 9.01 0.739
Male sex, n (%) 45 (48.9) 45 (48.9) 1.000
Body mass index (kg/m2) 25.01 ± 3.88 24.39 ± 3.24 0.344
Smoking, n (%) 19 (20.7) 18 (19.6) 0.854
Hypertension, n (%) 59 (64.1) 56 (60.9) 0.648
Dyslipidemia, n (%) 20 (23.0) 28 (32.9) 0.146
Statin, n (%) 39 (42.4) 31 (33.7) 0.224
Tube voltage of CT acquisition 0.499
100 kVp, n (%) 51 (55.4) 43 (46.7)
120 kVp, n (%) 36 (39.1) 43 (46.7)
140 kVp, n (%) 5 (5.4) 6 (6.5)
LAD-PCAT (HU) − 78.11 ± 8.01 − 75.04 ± 8.26 0.022
LCX-PCAT (HU) − 71.10 ± 8.13 − 68.31 ± 7.90 0.037
RCA-PCAT (HU) − 78.17 ± 8.64 − 73.35 ± 9.32 0.001

Data are presented as means ± standard deviations or the median (25th and 75th percentile), with the interquartile range in parentheses or number (%)

T2DM type 2 diabetes mellitus, GLDIS glucose-lowering drug interventions, PCAT Pericoronary adipose tissue, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery